George C. Clark - Net Worth and Insider Trading

George C. Clark Net Worth

The estimated net worth of George C. Clark is at least $57,235 dollars as of 2023-03-26. George C. Clark is the VP, Chief Accounting Officer of Biohaven Pharmaceutical Holding Co Ltd and owns about 4,065 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $57,235. Details can be seen in George C. Clark's Latest Holdings Summary section.

Transaction Summary of George C. Clark

To

George C. Clark Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, George C. Clark owns 2 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , and Biohaven Ltd (BHVN) .

Click here to see the complete history of George C. Clark’s form 4 insider trades.

Insider Ownership Summary of George C. Clark

Ticker Comapny Transaction Date Type of Owner
BHVN Biohaven Pharmaceutical Holding Co Ltd 2021-08-06 VP & Chief Accounting Officer
BHVN Biohaven Ltd 2022-11-08 VP & Chief Accounting Officer

George C. Clark Latest Holdings Summary

George C. Clark currently owns a total of 1 stock. George C. Clark owns 4,065 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of May 10, 2022, with a value of $57,235.

Latest Holdings of George C. Clark

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BHVN Biohaven Pharmaceutical Holding Co Ltd 2022-05-10 4,065 14.08 57,235

Holding Weightings of George C. Clark


George C. Clark Form 4 Trading Tracker

According to the SEC Form 4 filings, George C. Clark has made a total of 3 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the sale of 4,200 shares on May 10, 2022, which brought George C. Clark around $594,300.

Insider Trading History of George C. Clark

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2022-05-10
Sell
4,200.00
-50.82%
$141.50
$594,300.00
4,065.00
$14.08
-90.05%
2022-05-12
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2022-01-19
Sell
9,375.00
-60.92%
$117.01
$1,096,970.00
6,015.00
$14.08
-87.97%
2022-01-24
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2021-12-20
Sell
1,915.00
-18.86%
$123.84
$237,154.00
8,240.00
$14.08
-88.63%
2021-12-22
Total 3
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

George C. Clark Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

George C. Clark Ownership Network

Ownership Network List of George C. Clark

No Data

Ownership Network Relation of George C. Clark


George C. Clark Owned Company Details

What does Biohaven Pharmaceutical Holding Co Ltd do?

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.

Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?

George C. Clark is the VP & Chief Accounting Officer of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include Officer Matthew Buten , Chief Medical Officer Elyse Stock , and CCO-Migraine & Common Disease Jones William A Jr .

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary

Over the past 18 months, George C. Clark made 3 insider transaction in Biohaven Pharmaceutical Holding Co Ltd (BHVN) with a net sale of 15,490. Other recent insider transactions involving Biohaven Pharmaceutical Holding Co Ltd (BHVN) include a net sale of 62,265 shares made by Declan Doogan , a net purchase of 38,000 shares made by Gregory Bailey , and a net sale of 35,000 shares made by James Engelhart .

In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 153,613 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 43,000 shares were bought by its insiders, resulting in a net sale of 110,613 shares.

Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NYSE:BHVN Insider Transactions

20/Page
Total 0
Ticker
Insider
Position
Date
Buy/Sell
Shares
Shares Owned
Trade Price($)
Trade Percentage(%)
Cost($1000)
Price change since trade(%)
Share ownership details
Filing Date
20/Page
Total 0

George C. Clark Mailing Address

Above is the net worth, insider trading, and ownership report for George C. Clark. You might contact George C. Clark via mailing address: 215 Church Street, New Haven Ct 06510.